These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11070635)

  • 21. Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders.
    Sung M; Erkanli A; Angold A; Costello EJ
    Drug Alcohol Depend; 2004 Sep; 75(3):287-99. PubMed ID: 15283950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The five-year costs and benefits of extended psychological and psychiatric assessment versus standard intake interview for women with comorbid substance use disorders treated in compulsory care in Sweden.
    Olsson TM; Fridell M
    BMC Health Serv Res; 2018 Jan; 18(1):53. PubMed ID: 29378568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Child and adolescent mental health problems and substance use presentations to an emergency department.
    Bell L; Stargatt R; Bosanac P; Castle D; Braitberg G; Coventry N
    Australas Psychiatry; 2011 Dec; 19(6):521-5. PubMed ID: 22011197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders.
    Grella CE; Hser YI; Joshi V; Rounds-Bryant J
    J Nerv Ment Dis; 2001 Jun; 189(6):384-92. PubMed ID: 11434639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (2):CD001088. PubMed ID: 10796588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment area.
    Langås AM; Malt UF; Opjordsmoen S
    Eur Addict Res; 2012; 18(1):16-25. PubMed ID: 22042311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clients with substance abuse and mental health concerns: a guide for conducting intake interviews.
    Brems C; Johnson ME; Namyniuk LL
    J Behav Health Serv Res; 2002 Aug; 29(3):327-34. PubMed ID: 12216376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Private sector coverage of people with dual diagnoses.
    Garnick DW; Hendricks AM; Drainoni M; Horgan CM; Comstock C
    J Ment Health Adm; 1996; 23(3):317-28. PubMed ID: 10172688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and consequences of dual diagnosis.
    Buckley PF; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e01. PubMed ID: 17107226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Forensic psychiatric patients: Diagnoses, substance abuse, and criminal activity].
    Kramp P; Gabrielsen G
    Ugeskr Laeger; 2004 Aug; 166(34):2890-4. PubMed ID: 15449527
    [No Abstract]   [Full Text] [Related]  

  • 40. Point Prevalence and Patterns of Mental Health Comorbidity Among People Accessing Australia's First Older Adult-Specific Alcohol and Other Drug Treatment Service.
    Bright S; Walsh K; Williams C
    J Dual Diagn; 2018; 14(1):70-75. PubMed ID: 29023223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.